What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported ...

Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

The stock market overreacts to news ... meaningful but not something that would fundamentally change its perception of the business. Illumina is down 5.1% since the beginning of the year, and ...

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

Illumina has struggled to boost sales and consistently ... the uncertainty it introduced this week left the stock ripe for a fall when its earnings report left investors unimpressed.

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

At the time of writing Illumina stock is trading 5.14% lower at $124.36, according to data from Benzinga Pro.

Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 8.6% on ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...